YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FDJR2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,518
Award facts
- Contract value 100% obligated
- $2,518.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,518.16 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on January 29, 2026, with completion targeted for February 20, 2026. This firm fixed-price delivery order represents a routine pharmaceutical procurement supporting the Department of Defense's medical supply requirements. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to provide comprehensive pharmaceutical and medical consumable support to military healthcare facilities worldwide. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. As a prime vendor contractor under this program, DMS Pharmaceutical Group serves as a critical supplier within the federal military medical supply chain, with the YF-VAX order fulfilling routine vaccine distribution requirements for Department of Defense operations.
Quick answers
Who was awarded contract SPE2DR26FDJR2?
SPE2DR26FDJR2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FDJR2 worth?
The government has obligated $2,518 on SPE2DR26FDJR2.
Is contract SPE2DR26FDJR2 an order under another contract?
Yes. SPE2DR26FDJR2 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJR2 competed?
The extent of competition for SPE2DR26FDJR2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award